{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:49:28Z","timestamp":1761864568568,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.transci.2023.103809","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:37:15Z","timestamp":1694234235000},"page":"103809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?"],"prefix":"10.1016","volume":"62","author":[{"given":"Istemi","family":"Serin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omur Gokmen","family":"Sevindik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin","family":"Balik Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Melek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasa Gul","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulya","family":"Bilgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Bekoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylagul","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.transci.2023.103809_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2014.39","article-title":"Autologous hematopoietic stem cell mobilization in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","volume":"49","author":"Mohty","year":"2014","journal-title":"Bone Marrow Transpl"},{"year":"2019","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]","author":"Carreras","key":"10.1016\/j.transci.2023.103809_bib2"},{"issue":"3","key":"10.1016\/j.transci.2023.103809_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"10.1016\/j.transci.2023.103809_bib4","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1182\/blood.V86.12.4437.bloodjournal86124437","article-title":"Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers","volume":"86","author":"Grigg","year":"1995","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2023.103809_bib5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/bmt.2015.236","article-title":"A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma","volume":"51","author":"Silvennoinen","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"10.1016\/j.transci.2023.103809_bib6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"11","key":"10.1016\/j.transci.2023.103809_bib7","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/14712598.8.11.1797","article-title":"Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells","volume":"8","author":"Uy","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"10.1016\/j.transci.2023.103809_bib8","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.transci.2023.103809_bib9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.transci.2023.103809_bib10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood-2005-02-0468","article-title":"The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone","volume":"106","author":"Flomenberg","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.transci.2023.103809_bib11","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.transci.2023.103809_bib12","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V91.9.3148","article-title":"High CD34 (+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation","volume":"91","author":"Ketterer","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.transci.2023.103809_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/j.1537-2995.2011.03085.x","volume":"51","author":"Alexander","year":"2011","journal-title":"Transfusion"},{"issue":"23","key":"10.1016\/j.transci.2023.103809_bib14","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"3102 Investigators. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.transci.2023.103809_bib15","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.transci.2023.103809_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/vox.12397","article-title":"Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in hematological malignancies using biosimilar G-CSF","volume":"111","author":"Schmitt","year":"2016","journal-title":"Vox Sang"},{"issue":"10","key":"10.1016\/j.transci.2023.103809_bib17","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-11-3911","article-title":"Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma","volume":"103","author":"Kewalramani","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2023.103809_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbmt.2018.01.007","article-title":"Orchestration of chemomobilization and g-csf administration for successful hematopoietic stem cell collection","volume":"24","author":"Kriegsmann","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103809_bib19","doi-asserted-by":"crossref","unstructured":"Bilgin YM. Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update. J Blood Med. 2021 Jun 2;12:403\u2013412. doi: 10.2147\/JBM.S307520. Erratum in: J Blood Med. 13; 2022 Sep 05. p. 483\u20134.","DOI":"10.2147\/JBM.S307520"},{"key":"10.1016\/j.transci.2023.103809_bib20","doi-asserted-by":"crossref","unstructured":"H\u00fcbel K. Mobilization and Collection of HSC. In: Carreras E, Dufour C, Mohty M, Kr\u00f6ger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th ed. Cham (CH): Springer; 2019. Chapter 15.","DOI":"10.1007\/978-3-030-02278-5_15"},{"issue":"3","key":"10.1016\/j.transci.2023.103809_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hon.2286","article-title":"Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor","volume":"35","author":"Yuan","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.transci.2023.103809_bib22","article-title":"Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients","author":"Maechler","year":"2022","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1016\/j.transci.2023.103809_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103130","volume":"60","author":"Antelo","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.transci.2023.103809_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/trf.12265","article-title":"Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma","volume":"54","author":"Lanza","year":"2014","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:56:06Z","timestamp":1761468966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050223002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1473050223002136"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2023.103809","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2023.103809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103809"}}